Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer.
- DOI
- 10.1016/j.esmoop.2025.106057
- Published
- 2026 Feb
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2025.106057,
title = {Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer.},
author = {Lee JB and Kim KH and Yoon S and Song SY and Lee SS and Jo S and Ahn HK and Kim HJ and Choi SJ and Park H and Hong MH and Cho BC and Yoon HI and Lim SM},
year = {2026},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2025.106057},
url = {https://doi.org/10.1016/j.esmoop.2025.106057}
}RIS
TY - JOUR TI - Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer. AU - Lee JB AU - Kim KH AU - Yoon S AU - Song SY AU - Lee SS AU - Jo S AU - Ahn HK AU - Kim HJ AU - Choi SJ AU - Park H AU - Hong MH AU - Cho BC AU - Yoon HI AU - Lim SM PY - 2026 JO - ESMO open DO - 10.1016/j.esmoop.2025.106057 UR - https://doi.org/10.1016/j.esmoop.2025.106057 ER -
APA
JB, L., KH, K., S, Y., SY, S., SS, L., S, J., HK, A., HJ, K., SJ, C., H, P., MH, H., BC, C., HI, Y., & SM, L. (2026). Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer.. ESMO open. https://doi.org/10.1016/j.esmoop.2025.106057
Source records
- pubmed · retrieved 2026-09-26T05:21:56.515Z